Maximizing and evaluating the impact of test-trace-isolate programs: A modeling study
暂无分享,去创建一个
Elizabeth C. Lee | K. H. Grantz | E. C. Lee | L. D'Agostino McGowan | K. H. Lee | C. J. E. Metcalf | E. S. Gurley | J. Lessler | J. Lessler | K. Grantz | C. Metcalf | E. Gurley | Lucy D’Agostino McGowan | Kyu Han Lee | Lucy D039 | Agostino McGowan
[1] Policy brief: The impact of COVID-19 on children , 2020 .
[2] Georgia Salanti,et al. The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis , 2020, medRxiv.
[3] Daniel Eichner,et al. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020. , 2020, JAMA.
[4] P. E. Kopp,et al. Superspreading and the effect of individual variation on disease emergence , 2005, Nature.
[5] 鮫島 浩,et al. Population-based study からみた神経予後不良因子の検討 , 2009 .
[6] P. Klepac,et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts , 2020, The Lancet Global Health.
[7] Edward H. Kaplan,et al. Logistics of Aggressive Community Screening for Coronavirus 2019. , 2020, JAMA health forum.
[8] Sam Abbott,et al. Estimating the time-varying reproduction number of SARS-CoV-2 using national and subnational case counts , 2020, Wellcome Open Research.
[9] Robert C. Wolpert,et al. A Review of the , 1985 .
[10] Sebastian Funk,et al. Extended data: Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China , 2020 .
[11] A. Wagstaff,et al. A Cluster Randomized Trial , 2014 .
[12] A. Flahault,et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study , 2020, The Lancet.
[13] H. Tian,et al. Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China , 2020, BMJ Global Health.
[14] C. Fraser,et al. Factors that make an infectious disease outbreak controllable. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Hernán,et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study , 2020, The Lancet.
[16] Sarah V Leavitt,et al. HIT-COVID, a global database tracking public health interventions to COVID-19 , 2020, Scientific data.
[17] Tangchun Wu,et al. Reconstruction of the full transmission dynamics of COVID-19 in Wuhan , 2020, Nature.
[18] R. Morgan,et al. COVID-19: the gendered impacts of the outbreak , 2020, The Lancet.
[19] Márcia R. Ferreira,et al. A structured open dataset of government interventions in response to COVID-19 , 2020, Scientific Data.
[20] B. Giraudeau. [The cluster-randomized trial]. , 2004, Medecine sciences : M/S.
[21] S. Bhatt,et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study , 2020, The Lancet Global Health.
[22] Young Joon Park,et al. Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020 , 2020, Emerging infectious diseases.
[23] Sebastian Funk,et al. Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks , 2020, medRxiv.
[24] Ganna Rozhnova,et al. Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study , 2020, The Lancet Public Health.
[25] Joel Hellewell,et al. Using a real-world network to model localized COVID-19 control strategies , 2020, Nature Medicine.
[26] Sebastian Funk,et al. Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks. , 2020, Wellcome open research.
[27] Benjamin J. Cowling,et al. Respiratory virus shedding in exhaled breath and efficacy of face masks , 2020, Nature Medicine.
[28] H. Oshitani. Cluster-based approach to Coronavirus Disease 2019 (COVID-19) response in Japan-February-April 2020. , 2020, Japanese journal of infectious diseases.
[29] Milind Tambe,et al. Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance , 2020, medRxiv : the preprint server for health sciences.